Best Practices Forum - Heart Failure
Details & Video
This program offers participants downloadable slides and a program worksheet. View the PROGRAM MATERIALS tab for more information.
Overview & Objectives
This program was developed by the Canadian Collaborative Research Network. Through an engaging discussion with Canadian experts, this program covers the latest guidelines in heart failure and provides a practical approach to patient management issues.
This program is NOT accredited.
Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.
Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio.
|Heart Failure introductions||Milan Gupta|
|Does my dyspneic patient have heart failure?||Nadia Giannetti|
|The intersect between diabetes, kidney disease, and heart failure||Peter Liu|
|Rising creatinine and potassium, falling BP - help!||Nadia Giannetti|
|When and how to use sacubitril/valsartan in heart failure||Peter Liu|
|The heart failure crystal ball - SGLT2 inhibitors and cardiac myosin activators||Milan Gupta|
|Discussion period||All Faculty|
|Session close||All Faculty|
|Heart Failure introductions|
|Does my dyspneic patient have heart failure?|
|The intersect between diabetes, kidney disease, and heart failure|
|Rising creatinine and potassium, falling BP - help!|
|When and how to use sacubitril/valsartan in heart failure|
|The heart failure crystal ball - SGLT2 inhibitors and cardiac myosin activators|
Amgen Canada Inc.
Boehringer Ingelheim (Canada) Ltd.
Novartis Pharmaceuticals Canada Inc.